Harry Bartelink

1983–2024 年に発表

113
論文数
33,190
被引用数
88
h 指数
110
i10 指数

被引用数

Harry Bartelink の年別被引用数1972 年: 被引用 1 件1974 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 4 件1987 年: 被引用 4 件1988 年: 被引用 4 件1989 年: 被引用 9 件1990 年: 被引用 16 件1991 年: 被引用 13 件1992 年: 被引用 26 件1993 年: 被引用 32 件1994 年: 被引用 28 件1995 年: 被引用 48 件1996 年: 被引用 36 件1997 年: 被引用 39 件1998 年: 被引用 57 件1999 年: 被引用 64 件2000 年: 被引用 66 件2001 年: 被引用 121 件2002 年: 被引用 118 件2003 年: 被引用 208 件2004 年: 被引用 226 件2005 年: 被引用 290 件2006 年: 被引用 316 件2007 年: 被引用 376 件2008 年: 被引用 374 件2009 年: 被引用 350 件2010 年: 被引用 440 件2011 年: 被引用 338 件2012 年: 被引用 308 件2013 年: 被引用 306 件2014 年: 被引用 225 件2015 年: 被引用 247 件2016 年: 被引用 211 件2017 年: 被引用 203 件2018 年: 被引用 196 件2019 年: 被引用 553 件2020 年: 被引用 548 件2021 年: 被引用 441 件2022 年: 被引用 333 件2023 年: 被引用 190 件2024 年: 被引用 290 件2025 年: 被引用 106 件2026 年: 被引用 5 件1973 年は被引用が無いため表示していません1975〜1983 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,967 件、この内訳の 28.5%オランダ: 引用元論文 768 件、この内訳の 7.4%イギリス: 引用元論文 725 件、この内訳の 7%中国: 引用元論文 554 件、この内訳の 5.3%ドイツ: 引用元論文 506 件、この内訳の 4.8%フランス: 引用元論文 487 件、この内訳の 4.7%イタリア: 引用元論文 482 件、この内訳の 4.6%カナダ: 引用元論文 455 件、この内訳の 4.4%ベルギー: 引用元論文 293 件、この内訳の 2.8%オーストラリア: 引用元論文 271 件、この内訳の 2.6%スイス: 引用元論文 271 件、この内訳の 2.6%スペイン: 引用元論文 215 件、この内訳の 2.1%
0%28.5%その他 23.2%

分野

  • Biochemistry, Genetics and Molecular Biology45.3%
  • Medicine43.4%
  • Physics and Astronomy3.3%
  • Computer Science2.5%
  • Mathematics1.1%
  • Engineering1%
  • その他3.4%

トピック

  • Breast Cancer Treatment Studies10.2%
  • Breast Lesions and Carcinomas4%
  • Gene expression and cancer classification3.8%
  • Advanced Radiotherapy Techniques2.8%
  • Breast Implant and Reconstruction2.8%
  • Bioinformatics and Genomic Networks2.3%
  • その他74.1%

共著者

全論文

検索で開く
  1. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2002 被引用: 6,520

  2. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber ほか 67 名 - The Lancet 2019 被引用: 394

  3. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Blanchard, Jean Bourhis, Benjamin Lacas, Jean‐Pierre Pignon, Jacques Bernier, Quynh‐Thu Le, Jens Overgaard, Masheh KB Parmar, Andy Trotti, Jai Prakash Agarwal, Anne Aupérin, Kian Ang, Hassan K. Awwad, Almalina Bacigalupo, Harry Bartelink, E Benhamou, Jacques Bernier, Pierre Blanchard, Jean Bourhis, Wilfried Budach, Imjai Chitapanarux, Kwan Ho Cho, Laurence Collette, Renzo Corvò, Carla Dani, Stanley Dische, W. Dobrowsky, James W. Denham, C.M.L. Driessen, C. Fallai, Beth M. Beadle, Sarbani Ghosh Laskar, Sushmita Ghoshal, Cai Grau, Vincent Grégoire, John Hay, Carla van Herpen, A Hliniak, Jørgen Johansen, Claus Andrup Kristiansen, Valentina Krstevska, Benjamin Lacas, Johannes A. Langendijk, M. Lapeyre, Quynh‐Thu Le, Mohamed Lotayef, B. Maciejewski, P. Maingon, Wojciech Michalski, Sung Ho Moon, Per Nilsson, Patrizia Olmi, Matthew Nankivell, Kinji Nishiyama, Brian O’Sullivan, Jens Overgaard, Mahesh Parmar, Jean‐Pierre Pignon, Michael Poulsen, Kunnambath Ramadas, Anupam Rishi, David I. Rosenthal, Giuseppe Sanguineti, Michele I. Saunders, Christian Sire, Krzysztof Składowski, Luís Souhami, Rafał Suwiński, Z. Szutkowski, Nitin Tandon ほか 12 名 - The Lancet Oncology 2017 被引用: 339

  4. Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer

    著者: , , , , , , , - JNCI Journal of the National Cancer Institute 2007 被引用: 871

  5. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 682

  6. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 288

  7. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,021

  8. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

    著者: , , , , , , , , - Journal of Clinical Oncology 1997 被引用: 1,318

  9. Late cardiotoxicity after treatment for Hodgkin lymphoma

    著者: , , , , , , , , , , , - Blood 2006 被引用: 766

  10. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer

    著者: , , , , , - Clinical Cancer Research 2015 被引用: 188

  11. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

    著者: , , , , , , - Breast Cancer Research 2007 被引用: 609

  12. Increased Risk of Ischemic Stroke After Radiotherapy on the Neck in Patients Younger Than 60 Years

    著者: , , , , , , , - Journal of Clinical Oncology 2002 被引用: 249

  13. Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , - New England Journal of Medicine 1992 被引用: 1,287

  14. Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 1,046

  15. Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

    著者: , , , , , , , , , , , - New England Journal of Medicine 2001 被引用: 951

  16. Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 379

  17. Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer

    著者: , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 135

  18. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

    著者: , , , , , , , , - The Lancet Oncology 2012 被引用: 550

  19. Radiation-induced apoptosis

    著者: , - Cell and Tissue Research 2000 被引用: 288

  20. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

    著者: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2008 被引用: 224

  21. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2016 被引用: 142

  22. Assessment of set-up variability during deep inspiration breath hold radiotherapy for breast cancer patients by 3D-surface imaging

    著者: , , , , , - Radiotherapy and Oncology 2013 被引用: 99

  23. Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2006 被引用: 663

  24. Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

    著者: , , , , , , , , , - Journal of Clinical Oncology 2001 被引用: 570